Wegovy, Zepbound Side Effects, and Wegovy Pills: What You Need to Know in 2025

Wegovy (semaglutide) and Zepbound (tirzepatide) are the two most effective weight loss medications currently available, and both come with real side effects that you should understand before starting treatment. Wegovy is also now being developed in pill form, which could change how millions of people access this medication. As a bariatric surgeon who has performed over 4,000 surgeries and worked with patients on GLP-1 medications for years, I want to give you a straightforward breakdown of what these drugs do, how they differ, and what side effects you should actually worry about.

How Does Wegovy Work for Weight Loss?

Wegovy contains semaglutide, which mimics a hormone called GLP-1 that your body naturally produces after eating. This hormone tells your brain that you are full, slows down how quickly food leaves your stomach, and helps regulate blood sugar. The injectable form of Wegovy delivers semaglutide once a week through a small pen injection that most patients describe as painless.

In the STEP clinical trial program, patients taking Wegovy lost an average of about 15% of their body weight over 68 weeks. That is a meaningful amount of weight loss, and for many patients it translates into improvements in blood pressure, blood sugar, cholesterol, joint pain, and sleep apnea.

However, I tell my patients something that does not get enough attention: this medication works best when combined with real changes in eating habits and physical activity. Without those foundational changes, the weight tends to come back if the medication is stopped. A study published in Diabetes, Obesity and Metabolism in 2022 showed that patients regained approximately two-thirds of lost weight within a year of stopping semaglutide.

What Are the Most Common Zepbound Side Effects?

Zepbound (tirzepatide) is a dual-action medication that targets both GLP-1 and GIP receptors. It was approved by the FDA for weight loss in late 2023, and in clinical trials it produced even greater average weight loss than semaglutide, with patients in the SURMOUNT-1 trial losing up to 22.5% of body weight on the highest dose.

But greater potency often means more side effects, and Zepbound is no exception. Here are the side effects I see most commonly in my practice:

Gastrointestinal Side Effects

The most frequent Zepbound side effects are nausea, vomiting, diarrhea, and constipation. In the SURMOUNT trials, nausea affected roughly 24-33% of patients depending on the dose. Vomiting occurred in about 6-12% of patients. Most of these symptoms are worst during the first few weeks and during dose increases, then gradually improve.

I counsel my patients to eat smaller meals, avoid greasy or heavy foods, stay hydrated, and eat slowly. These simple steps make a real difference. Some patients also benefit from anti-nausea medication during the initial adjustment period.

Fatigue and Low Energy

Some patients on Zepbound report feeling tired or having less energy, especially in the early weeks. This is partly because you are eating significantly less food than before. Making sure you are getting adequate protein (I recommend at least 60-80 grams per day) and staying hydrated helps considerably.

Injection Site Reactions

Mild redness, itching, or bruising at the injection site happens occasionally. This is almost always minor and resolves on its own.

More Serious but Rare Side Effects

There are some Zepbound side effects that require immediate medical attention:

• Pancreatitis: Severe abdominal pain that radiates to the back, especially with nausea and vomiting, needs evaluation right away. This is rare but documented.
• Gallbladder problems: Rapid weight loss from any cause increases gallstone risk. Zepbound is no different. Symptoms include right upper abdominal pain, especially after eating fatty foods.
• Thyroid tumors: Tirzepatide carries a boxed warning about thyroid C-cell tumors based on animal studies. This has not been confirmed in humans, but patients with a personal or family history of medullary thyroid carcinoma should not take Zepbound.
• Gastroparesis: In rare cases, the slowing of stomach emptying can become severe. If you feel full for hours after eating a small meal or are vomiting undigested food, contact your doctor.

How Do Wegovy and Zepbound Side Effects Compare?

The side effect profiles of Wegovy and Zepbound are similar because both medications work through GLP-1 pathways. However, there are some practical differences I have noticed in my clinical experience:

Zepbound tends to cause slightly more nausea during dose escalation, but it also tends to produce more weight loss. Some patients who cannot tolerate one medication do fine on the other, so switching is a reasonable strategy if side effects are unmanageable.

Both medications carry the same warnings regarding pancreatitis, gallbladder disease, and thyroid concerns. Neither should be used during pregnancy or in combination with other GLP-1 receptor agonists.

One thing I emphasize with patients: the gastrointestinal side effects are not a sign that the medication is working. Some patients think they need to feel nauseous to lose weight, and that is simply not true. The appetite suppression happens regardless of whether you experience nausea.

What Are Wegovy Pills and When Will They Be Available?

Novo Nordisk, the maker of Wegovy, has been developing an oral form of semaglutide for weight loss. Oral semaglutide already exists for diabetes treatment under the brand name Rybelsus, but it uses a lower dose. The new oral formulation for weight loss would use higher doses and is being studied in the OASIS clinical trial program.

Results from the OASIS 1 trial, published in The Lancet in 2023, showed that oral semaglutide at a 50mg daily dose produced about 15.1% body weight loss over 68 weeks, which is comparable to the injectable version.

Wegovy pills would be a significant development for several reasons:

No More Injections

Many patients hesitate to start Wegovy because of the weekly injection. Even though the injection is straightforward and uses a tiny needle, some people have a genuine fear of needles. An oral option would remove that barrier entirely.

Supply Chain Benefits

The ongoing shortage of injectable GLP-1 medications has been a major frustration for patients and doctors alike. Pills are generally easier to manufacture at scale than injectable pens, which could help with availability.

How Wegovy Pills Would Need to Be Taken

Oral semaglutide requires specific instructions to work properly. Based on the existing Rybelsus formulation, patients would need to take the pill on an empty stomach with no more than four ounces of plain water, then wait at least 30 minutes before eating, drinking, or taking other medications. This is because semaglutide is a peptide that gets broken down by stomach acid, so the pill contains a special absorption enhancer that only works under specific conditions.

This is an important detail. If you eat breakfast right after taking the pill or take it with coffee, the medication will not be absorbed properly and you will not get the full benefit.

Expected Timeline

As of early 2025, the oral semaglutide formulation for weight loss is still working through the FDA approval process. Most experts expect it could become available in late 2025 or 2026, but regulatory timelines are unpredictable.

Who Is a Good Candidate for Wegovy or Zepbound?

Both medications are FDA-approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol.

In my practice, I consider several factors when recommending these medications:

• How much weight needs to be lost: For patients who need to lose 15-25% of their body weight, Wegovy or Zepbound may be sufficient. For patients who need to lose more than that, bariatric surgery often provides more durable results.
• Previous weight loss attempts: I want to know what you have tried before and why it did not work long-term.
• Medical history: Certain conditions like medullary thyroid carcinoma, pancreatitis history, or pregnancy rule out these medications.
• Realistic expectations: These drugs are not magic. They reduce appetite and help with portion control, but they do not change your food environment, your habits, or your relationship with food. Patients who pair medication with behavioral changes get the best outcomes.

Can You Use Wegovy or Zepbound Instead of Bariatric Surgery?

This is a question I hear almost daily. The honest answer is: it depends on your situation.

For patients with a BMI over 40, or a BMI over 35 with significant health conditions, bariatric surgery still produces greater and more sustained weight loss than any medication currently available. Gastric sleeve and gastric bypass surgeries typically result in 25-35% total body weight loss, and long-term data going back decades supports the durability of surgical results.

Medications like Wegovy and Zepbound are excellent tools, but they require ongoing use to maintain results. Surgery changes the anatomy permanently, which is why the weight loss tends to last longer.

That said, not every patient is ready for surgery or is a good surgical candidate. Some patients prefer to try medication first, and that is a perfectly reasonable approach. Others use medication as a bridge before surgery or as an addition after surgery if they experience weight regain.

Having performed over 4,000 bariatric procedures over more than 20 years, I can tell you there is no single right answer for every patient. The best approach is the one that accounts for your specific health situation, your goals, and what you are willing to commit to long-term.

How to Manage Side Effects If You Are Taking These Medications

Here are the strategies I recommend to my patients for minimizing side effects on Wegovy or Zepbound:

• Start at the lowest dose and increase gradually as directed. Rushing dose escalation is the number one cause of severe nausea.
• Eat smaller, more frequent meals instead of two or three large ones.
• Prioritize protein at every meal. This helps maintain muscle mass during weight loss and keeps you feeling satisfied longer.
• Stay hydrated. Dehydration makes nausea and constipation worse.
• Avoid trigger foods. Most patients notice that fried foods, very rich meals, and large portions of carbohydrates cause the most discomfort.
• Take your injection at bedtime if nausea is a problem. Some patients find that sleeping through the initial hours after injection reduces symptoms.
• Report severe or persistent symptoms to your prescribing doctor. Adjusting the dose or switching medications is sometimes necessary.

What Should You Do Next?

If you are considering Wegovy, Zepbound, or the upcoming Wegovy pills for weight loss, the most important step is getting an evaluation from a physician who understands both medical and surgical weight loss options. Too many patients get started on these medications by doctors who do not have the expertise to guide them through dose adjustments, side effect management, or transitions to other treatments if needed.

I recommend scheduling a consultation with a weight loss specialist who can review your full medical history, discuss realistic expectations, and help you decide whether GLP-1 medications, bariatric surgery, or a combination approach makes the most sense for your situation. The right plan is the one built specifically for you.